- Home
- CEV vs TELA Comparison
CEV vs TELA Comparison
Compare CEV & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- TELA
- Stock Information
- Founded
- CEV 1999
- TELA 2012
- Country
- CEV United States
- TELA United States
- Employees
- CEV N/A
- TELA N/A
- Industry
- CEV Finance/Investors Services
- TELA Medical/Dental Instruments
- Sector
- CEV Finance
- TELA Health Care
- Exchange
- CEV Nasdaq
- TELA Nasdaq
- Market Cap
- CEV 69.7M
- TELA 70.1M
- IPO Year
- CEV N/A
- TELA 2019
- Fundamental
- Price
- CEV $10.01
- TELA $1.58
- Analyst Decision
- CEV
- TELA Buy
- Analyst Count
- CEV 0
- TELA 3
- Target Price
- CEV N/A
- TELA $5.33
- AVG Volume (30 Days)
- CEV 19.6K
- TELA 79.7K
- Earning Date
- CEV 01-01-0001
- TELA 11-06-2025
- Dividend Yield
- CEV 4.23%
- TELA N/A
- EPS Growth
- CEV N/A
- TELA N/A
- EPS
- CEV 0.36
- TELA N/A
- Revenue
- CEV N/A
- TELA $75,323,000.00
- Revenue This Year
- CEV N/A
- TELA $25.72
- Revenue Next Year
- CEV N/A
- TELA $22.03
- P/E Ratio
- CEV $29.36
- TELA N/A
- Revenue Growth
- CEV N/A
- TELA 16.34
- 52 Week Low
- CEV $8.83
- TELA $0.86
- 52 Week High
- CEV $10.91
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- CEV 77.83
- TELA 41.77
- Support Level
- CEV $9.89
- TELA $1.53
- Resistance Level
- CEV $10.01
- TELA $1.73
- Average True Range (ATR)
- CEV 0.07
- TELA 0.15
- MACD
- CEV 0.05
- TELA -0.01
- Stochastic Oscillator
- CEV 88.89
- TELA 16.67
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.